Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03414359 · ClinicalTrials.gov registry record · Early Phase 1
Comparison of Chloroprocaine vs Lidocaine for Epidural Anesthesia in Cesarean Delivery
A Early Phase 1 study, sponsored by University of Arkansas.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 70
- Enrollment target
NCT03414359 is a Early Phase 1 study that has completed, run by University of Arkansas. The registered enrollment target is 70 participants.
The verdict
NCT03414359, a Early Phase 1 study, has completed, sponsored by University of Arkansas.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 70 participants
- Enrollment target
Study Summary
Regional anesthesia is commonly used for elective and emergency cesarean delivery. It provides numerous safety advantages when compared to general anesthesia for both the mother and fetus1. Epidurals also have the added benefit of being able to provide pain relief throughout labor and in the event of cesarean delivery, epidural analgesia can be "extended" to provide surgical anesthesia. Numerous studies have been performed to assess the onset times of various local anesthetics when administered through an epidural catheter. Attempts to reduce anesthetic onset time and improve the quality of intraoperative analgesia have been attempted by using different local anesthetic solutions and by the addition of other drugs to the epidural solution (such as epinephrine, fentanyl and sodium bicarbonate).
Interventions
- DRUG 2% Lidocaine
- DRUG 3% Chloroprocaine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 70 participants |
| Start Date | 2018-02-15 |
| Est. Completion | 2019-03-27 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03414359
The ClinicalTrials.gov registry entry for NCT03414359 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 70 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Arkansas, which has 318 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which 2% Lidocaine is the first listed.
NCT03414359 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03414359 about?
NCT03414359 is a clinical study titled "Comparison of Chloroprocaine vs Lidocaine for Epidural Anesthesia in Cesarean Delivery". Regional anesthesia is commonly used for elective and emergency cesarean delivery. It provides numerous safety advantages when compared to general anesthesia for both the mother and fetus1. Epidurals also have the added benefit of being able to provide pain relief throughout labor and in the event o...
What is the current status of trial NCT03414359?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 70 participants. The study started on 2018-02-15. Estimated completion is 2019-03-27.
What interventions are being tested in trial NCT03414359?
The interventions under investigation include: 2% Lidocaine (DRUG), 3% Chloroprocaine (DRUG).
Who is sponsoring clinical trial NCT03414359?
This trial is sponsored by University of Arkansas, which has 318 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.